• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用[11C]KR31173对血管紧张素Ⅱ1型受体进行正电子发射断层显像。

PET Imaging of the AT1 receptor with [11C]KR31173.

作者信息

Zober Tamas G, Mathews William B, Seckin Esen, Yoo Sung-Eun, Hilton John, Xia Jinsong, Sandberg Kathryn, Ravert Hayden T, Dannals Robert F, Szabo Zsolt

机构信息

Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21287-0817, USA.

出版信息

Nucl Med Biol. 2006 Jan;33(1):5-13. doi: 10.1016/j.nucmedbio.2005.08.005.

DOI:10.1016/j.nucmedbio.2005.08.005
PMID:16459253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1819586/
Abstract

AIM

The goal of this study was to investigate the binding characteristics of [(11)C]KR31173 and its applicability for PET studies of the AT(1) receptor (AT(1)R).

METHODS

Ex vivo biodistribution and pharmacology were tested in mice. PET imaging was performed in mice, beagle dogs and a baboon. To assess nonspecific binding, PET imaging was performed both before and after pretreatment with a potent AT(1)R antagonist. In the baboon, PET imaging was also performed with the previously developed radioligand [(11)C]L-159,884 for comparison.

RESULTS

Ex vivo biodistribution studies in mice showed specific binding rates of 80-90% in the adrenals, kidneys, lungs and heart. Specific binding was confirmed in mice using small animal PET. In dogs, renal cortex tissue concentration at 75-95 min postinjection (pi) was 63 nCi/ml per millicurie at a specific binding rate of 95%. In the baboon renal cortex, tissue activity at 55-75 min pi was 345 nCi/ml per millicurie. In the baboon the specific binding of [(11)C]KR31173 was higher (81%) than the specific binding of [(11)C]L-159,884 (34%).

CONCLUSION

[(11)C]KR31173 shows accumulation and significant specific binding to the AT(1)R in the kidneys of mice, dogs and baboon. These findings suggest that this radioligand is suited for imaging the renal cortical AT(1)R in multiple species.

摘要

目的

本研究旨在探究[(11)C]KR31173的结合特性及其在血管紧张素Ⅱ1型受体(AT(1)R)正电子发射断层显像(PET)研究中的适用性。

方法

在小鼠体内进行了离体生物分布和药理学测试。对小鼠、比格犬和一只狒狒进行了PET成像。为评估非特异性结合,在给予强效AT(1)R拮抗剂预处理前后均进行了PET成像。在狒狒身上,还使用先前开发的放射性配体[(11)C]L-159,884进行PET成像以作比较。

结果

小鼠的离体生物分布研究显示,肾上腺、肾脏、肺和心脏的特异性结合率为80% - 90%。使用小动物PET在小鼠体内证实了特异性结合。在犬类中,注射后75 - 95分钟时肾皮质组织浓度为每毫居里63纳居里/毫升,特异性结合率为95%。在狒狒的肾皮质中,注射后55 - 75分钟时组织活性为每毫居里345纳居里/毫升。在狒狒体内,[(11)C]KR31173的特异性结合(81%)高于[(11)C]L-159,884的特异性结合(34%)。

结论

[(11)C]KR31173在小鼠、犬类和狒狒的肾脏中显示出对AT(1)R的积聚和显著特异性结合。这些发现表明,这种放射性配体适用于对多个物种的肾皮质AT(1)R进行成像。

相似文献

1
PET Imaging of the AT1 receptor with [11C]KR31173.利用[11C]KR31173对血管紧张素Ⅱ1型受体进行正电子发射断层显像。
Nucl Med Biol. 2006 Jan;33(1):5-13. doi: 10.1016/j.nucmedbio.2005.08.005.
2
A novel radioligand for imaging the AT1 angiotensin receptor with PET.一种用于正电子发射断层扫描(PET)成像AT1血管紧张素受体的新型放射性配体。
Nucl Med Biol. 2004 Jul;31(5):571-4. doi: 10.1016/j.nucmedbio.2003.10.014.
3
Image-derived and arterial blood sampled input functions for quantitative PET imaging of the angiotensin II subtype 1 receptor in the kidney.用于肾脏中血管紧张素II 1型受体定量PET成像的图像衍生和动脉血采样输入函数。
Med Phys. 2015 Nov;42(11):6736-44. doi: 10.1118/1.4934375.
4
Modeling of the renal kinetics of the AT1 receptor specific PET radioligand [11C]KR31173.AT1 受体特异性 PET 放射性配体 [11C]KR31173 的肾脏动力学建模。
Biomed Res Int. 2013;2013:835859. doi: 10.1155/2013/835859. Epub 2013 Sep 8.
5
Evaluation of [(11)C]methyl-losartan and [(11)C]methyl-EXP3174 for PET imaging of renal AT1receptor in rats.[(11)C]甲基氯沙坦和[(11)C]甲基EXP3174用于大鼠肾脏AT1受体PET成像的评估。
Nucl Med Biol. 2015 Nov;42(11):850-7. doi: 10.1016/j.nucmedbio.2015.06.012. Epub 2015 Jun 30.
6
Synthesis and in vivo evaluation of a PET radioligand for imaging the endothelin-A receptor.用于内皮素-A受体成像的正电子发射断层显像(PET)放射性配体的合成及体内评价
Nucl Med Biol. 2006 Jan;33(1):15-9. doi: 10.1016/j.nucmedbio.2005.07.012.
7
Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.用于内皮素-A受体成像的新型正电子发射断层显像(PET)放射性配体的合成及体内评价
J Nucl Med. 2008 Sep;49(9):1529-36. doi: 10.2967/jnumed.108.051565. Epub 2008 Aug 14.
8
Positron-emission tomography imaging of the angiotensin II subtype 1 receptor in swine renal artery stenosis.猪肾动脉狭窄中血管紧张素II 1型受体的正电子发射断层扫描成像
Hypertension. 2008 Feb;51(2):466-73. doi: 10.1161/HYPERTENSIONAHA.107.102715. Epub 2008 Jan 2.
9
Investigation of angiotensin II/AT1 receptors with carbon-11-L-159,884: a selective AT1 antagonist.
J Nucl Med. 1998 Jul;39(7):1209-13.
10
Analysis of [11C]methyl-candesartan kinetics in the rat kidney for the assessment of angiotensin II type 1 receptor density in vivo with PET.用 PET 评估大鼠肾脏中血管紧张素 II 型 1 受体密度的[11C]甲基坎地沙坦动力学分析。
Nucl Med Biol. 2013 Feb;40(2):252-61. doi: 10.1016/j.nucmedbio.2012.10.013.

引用本文的文献

1
Enabling Noninvasive Visualization of AT1R Through a New F PET Radiotracer.通过新型氟代正电子发射断层显像(PET)放射性示踪剂实现血管紧张素Ⅱ1型受体(AT1R)的无创可视化。
Hypertension. 2025 Oct;82(10):1638-1640. doi: 10.1161/HYPERTENSIONAHA.125.25620. Epub 2025 Sep 17.
2
Redefining AT1 Receptor PET Imaging: Introducing the Radiotracer [F]DR29.重新定义血管紧张素Ⅱ1型受体正电子发射断层显像:引入放射性示踪剂[F]DR29。
Hypertension. 2025 Oct;82(10):1626-1637. doi: 10.1161/HYPERTENSIONAHA.124.24441. Epub 2025 Aug 8.
3
Medicinal (Radio) Chemistry: Building Radiopharmaceuticals for the Future.

本文引用的文献

1
Cancer, inflammation and the AT1 and AT2 receptors.癌症、炎症与1型和2型血管紧张素受体
J Inflamm (Lond). 2004 Sep 30;1(1):3. doi: 10.1186/1476-9255-1-3.
2
A tracer kinetic model for 18F-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET.一种用于18F-FHBG的示踪动力学模型,用于使用正电子发射断层扫描(PET)定量活体动物中单纯疱疹病毒1型胸苷激酶报告基因的表达。
J Nucl Med. 2004 Sep;45(9):1560-70.
3
A novel radioligand for imaging the AT1 angiotensin receptor with PET.一种用于正电子发射断层扫描(PET)成像AT1血管紧张素受体的新型放射性配体。
药用(放射性)化学:为未来构建放射性药物。
Curr Med Chem. 2024;31(34):5481-5534. doi: 10.2174/0929867331666230818092634.
4
Synthesis of the Novel AT Receptor Tracer [F]Fluoropyridine-Candesartan via Click Chemistry.通过点击化学合成新型血管紧张素Ⅱ受体拮抗剂示踪剂[F]氟吡啶 - 坎地沙坦
ACS Omega. 2020 Aug 3;5(32):20353-20362. doi: 10.1021/acsomega.0c02310. eCollection 2020 Aug 18.
5
Novel F-Labeled PET Imaging Agent FV45 Targeting the Renin-Angiotensin System.靶向肾素-血管紧张素系统的新型F标记PET显像剂FV45
ACS Omega. 2018 Sep 30;3(9):10460-10470. doi: 10.1021/acsomega.8b01885. Epub 2018 Sep 4.
6
Cardiac molecular imaging to track left ventricular remodeling in heart failure.用于追踪心力衰竭中左心室重构的心脏分子成像。
J Nucl Cardiol. 2017 Apr;24(2):574-590. doi: 10.1007/s12350-016-0620-2. Epub 2016 Aug 1.
7
Radionuclide imaging of neurohormonal system of the heart.心脏神经激素系统的放射性核素成像
Theranostics. 2015 Feb 15;5(6):545-58. doi: 10.7150/thno.10900. eCollection 2015.
8
Novel molecular angiotensin converting enzyme and angiotensin receptor imaging techniques.新型分子血管紧张素转换酶和血管紧张素受体成像技术。
Curr Cardiol Rep. 2014 Apr;16(4):466. doi: 10.1007/s11886-014-0466-7.
9
Modeling of the renal kinetics of the AT1 receptor specific PET radioligand [11C]KR31173.AT1 受体特异性 PET 放射性配体 [11C]KR31173 的肾脏动力学建模。
Biomed Res Int. 2013;2013:835859. doi: 10.1155/2013/835859. Epub 2013 Sep 8.
10
Molecular hybrid positron emission tomography/computed tomography imaging of cardiac angiotensin II type 1 receptors.心肌血管紧张素 II 型 1 受体的分子杂交正电子发射断层扫描/计算机断层扫描成像。
J Am Coll Cardiol. 2012 Dec 18;60(24):2527-34. doi: 10.1016/j.jacc.2012.09.023. Epub 2012 Nov 14.
Nucl Med Biol. 2004 Jul;31(5):571-4. doi: 10.1016/j.nucmedbio.2003.10.014.
4
Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.使用18F-FDG动态扫描、ATLAS小动物PET扫描仪和动脉血采样技术测量麻醉大鼠的脑葡萄糖代谢率。
J Nucl Med. 2004 Apr;45(4):665-72.
5
In vivo investigation of estrogen regulation of adrenal and renal angiotensin (AT1) receptor expression by PET.通过正电子发射断层扫描(PET)对雌激素调节肾上腺和肾血管紧张素(AT1)受体表达进行体内研究。
J Nucl Med. 2004 Jan;45(1):94-100.
6
Estrogen regulates adrenal angiotensin AT1 receptors by modulating AT1 receptor translation.雌激素通过调节1型血管紧张素受体(AT1)的翻译来调控肾上腺血管紧张素AT1受体。
Endocrinology. 2003 Jul;144(7):3251-61. doi: 10.1210/en.2003-0015.
7
Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II.
Hypertension. 2002 Jan;39(1):75-80. doi: 10.1161/hy0102.100788.
8
Use of positron emission tomography to study AT1 receptor regulation in vivo.
J Am Soc Nephrol. 2001 Jul;12(7):1350-1358. doi: 10.1681/ASN.V1271350.
9
Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms.血管紧张素II 1型受体与促肾上腺皮质激素受体在人肾上腺皮质肿瘤中的表达
Clin Endocrinol (Oxf). 2001 May;54(5):627-32. doi: 10.1046/j.1365-2265.2001.01253.x.
10
Protective effect of agiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver.血管紧张素II 1型受体拮抗剂CV-11974对肝脏缺血再灌注损伤的保护作用
Transplantation. 2001 Apr 27;71(8):1034-9. doi: 10.1097/00007890-200104270-00003.